Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy
- 1 September 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (9) , 1409-1411
- https://doi.org/10.1016/0277-5379(87)90128-3
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- MULTIFACTORIAL DRUG-RESISTANCE IN AN ADRIAMYCIN-RESISTANT HUMAN SMALL-CELL LUNG-CARCINOMA CELL-LINE1987
- Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates.Journal of Clinical Oncology, 1986
- Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.Journal of Clinical Oncology, 1986
- Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.Journal of Clinical Oncology, 1985
- Small-Cell Carcinoma of Lung: Reinduction Therapy After Late RelapseAnnals of Internal Medicine, 1983